These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12625212)

  • 1. Recap of FDA product approvals--2002.
    Am J Health Syst Pharm; 2003 Feb; 60(4):310, 312. PubMed ID: 12625212
    [No Abstract]   [Full Text] [Related]  

  • 2. 2011 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2012 Feb; 11(2):91-4. PubMed ID: 22293555
    [No Abstract]   [Full Text] [Related]  

  • 3. Recap of FDA product approvals--1999.
    Miller JL
    Am J Health Syst Pharm; 2000 Mar; 57(5):418, 421-2. PubMed ID: 10711519
    [No Abstract]   [Full Text] [Related]  

  • 4. Recap of FDA product approvals--2000.
    Traynor K
    Am J Health Syst Pharm; 2001 Mar; 58(5):363, 366-8. PubMed ID: 11258167
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA advisory panels recommend Lotronex be put back on market.
    Charatan F
    BMJ; 2002 May; 324(7345):1053. PubMed ID: 11993482
    [No Abstract]   [Full Text] [Related]  

  • 6. Recap of FDA product approvals--2001.
    Traynor K
    Am J Health Syst Pharm; 2002 Feb; 59(4):321-2, 324. PubMed ID: 11885393
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA new drug approvals in Q1 2021.
    Urquhart L
    Nat Rev Drug Discov; 2021 May; 20(5):334. PubMed ID: 33854219
    [No Abstract]   [Full Text] [Related]  

  • 8. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2012 Mar; 50(3):11-2. PubMed ID: 22390784
    [No Abstract]   [Full Text] [Related]  

  • 9. 2023 in review: FDA approvals of new medicines.
    Kinch MS; Kraft Z; Schwartz T
    Drug Discov Today; 2024 May; 29(5):103966. PubMed ID: 38552777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA advisers warn of more deaths if drug is relaunched.
    Moynihan R
    BMJ; 2002 Sep; 325(7364):561. PubMed ID: 12228121
    [No Abstract]   [Full Text] [Related]  

  • 11. FDA recommends bringing controversial IBS drug back.
    McCarthy M
    Lancet; 2002 Apr; 359(9316):1491-2. PubMed ID: 11988253
    [No Abstract]   [Full Text] [Related]  

  • 12. Despite surge in orphan drug designations, approvals still lag.
    Heger M
    Nat Med; 2011 Mar; 17(3):236. PubMed ID: 21383708
    [No Abstract]   [Full Text] [Related]  

  • 13. Clip & save: drug chart. FDA-approved drugs to treat ADHD.
    J Psychosoc Nurs Ment Health Serv; 2010 Mar; 48(3):9-10. PubMed ID: 20302260
    [No Abstract]   [Full Text] [Related]  

  • 14. Conflicting information from TGA versus FDA may undermine compliance with use of medication.
    Beckmann KM
    Med J Aust; 2013 Jul; 199(1):28-9. PubMed ID: 23829255
    [No Abstract]   [Full Text] [Related]  

  • 15. Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?
    Rodriguez-Monguio R; Spargo T; Seoane-Vazquez E
    Orphanet J Rare Dis; 2017 Jan; 12(1):1. PubMed ID: 28057032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacology and orphan drugs: an informational inventory 2006-2010.
    Bashaw ED; Fang L
    Clin Pharmacol Ther; 2012 May; 91(5):932-6. PubMed ID: 22453190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Treatments for Rare Cancers: The U.S. Orphan Drug Act Is Delivering-A Cross-Sectional Analysis.
    Stockklausner C; Lampert A; Hoffmann GF; Ries M
    Oncologist; 2016 Apr; 21(4):487-93. PubMed ID: 27022038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of orphan drug applications that fail to achieve marketing approval in the USA.
    Heemstra HE; Leufkens HG; Rodgers RP; Xu K; Voordouw BC; Braun MM
    Drug Discov Today; 2011 Jan; 16(1-2):73-80. PubMed ID: 21094692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The latest drugs on the FDA's radar.
    Waldron T
    Behav Healthc; 2006 Jun; 26(6):34-5. PubMed ID: 16833213
    [No Abstract]   [Full Text] [Related]  

  • 20. FDA OK's two drugs for irritable bowel syndrome. The arsenal of IBS drugs is growing, but diagnosis is tricky.
    Horwitz BJ
    Health News; 2002 Oct; 8(10):1-2. PubMed ID: 12416480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.